メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部・臨床総合医学
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(1)
研究成果
(67)
フィンガープリント
医学部・臨床総合医学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Isolated Rat Hepatocytes
31%
Metabolic Effects
31%
NUP98-HOXA9
31%
Pheochromocytoma
31%
Glibenclamide
31%
Human mAb
31%
Diagnostic Specimen
31%
Streptomyces Olivochromogenes
31%
Antimicrobial Properties
31%
Epstein-Barr Virus-positive mucocutaneous Ulcer
31%
DNA Detection
31%
Disease Effects
31%
Ketogenesis
31%
Nitric Oxide Donors
31%
Hematopoietic Function
31%
Relapsed Lymphoma
31%
Wall Thinning
31%
CBDCA
31%
Combination of Therapies
31%
Severe Hepatitis
31%
CHOP Chemotherapy
31%
Rituximab-CHOP
31%
Left Ventricular Wall
31%
Antiviral Prophylaxis
31%
Cardiac muscle Cells
31%
Cardiac Biopsy
31%
Human Endothelial Cells
31%
VPS13B
31%
Cohen Syndrome
31%
Lymphocytic Myocarditis
31%
Bystander Cells
31%
Japan
31%
Mannich Derivatives
31%
Anticancer Properties
31%
Varicella Outbreak
31%
2,4-Diamino-6-hydroxypyrimidine
31%
Rituximab-containing Chemotherapy
31%
Lymphoma Patients
31%
B-cell Lymphoma
31%
Induction Chemotherapy
31%
In Vitro Anticancer Activity
31%
National Survey
31%
DEK-NUP214
31%
Solanum Torvum Swartz
31%
COL12A1
31%
Chromosome 9
31%
NUP214
31%
Variant Translocation
31%
Cardiac Sarcoidosis
31%
Complex Variants
31%
Steroid Therapy
31%
Methyl Caffeate
31%
Eosinophilic Myocarditis
31%
Serum IgG Level
31%
R-CHOP Therapy
31%
System Restoration
31%
9,10-anthraquinone
31%
COX-2 Inhibition
31%
Acute Myeloblastic Leukemia
31%
Suboptimal Response
31%
Successful Pregnancy
31%
Cibenzoline
31%
Fabry Disease
31%
T Cell Receptor-like Antibody
31%
Antibody-antigen
31%
Fusion Transcript
31%
ETV6
31%
Major Molecular Response
23%
MCF-7 Cells
22%
Tetrahymena
20%
Protozoa
20%
Myocarditis
20%
Pteridine Derivatives
20%
Interventricular Septum
19%
BH 4
18%
Calvert Formula
17%
Induction Therapy
17%
Poly(A) Tail
15%
Ketogenic
15%
Ann Arbor Staging
15%
Immunosenescence
15%
Hypokinesia
15%
Atrioventricular Block
15%
Acute Inferior Myocardial Infarction
15%
Small Round Cell
15%
Unselected Patients
15%
Posterior Wall
13%
Epstein-Barr Virus-encoded RNA
13%
Glyceraldehyde-3-phosphate Dehydrogenase
13%
Cytotoxic Properties
13%
Ethyl Acetate
13%
Non-neuronal
12%
Myocardial Lesion
11%
Mudumalai
10%
Fermentation Medium
10%
β-lactamase Enzymes
10%
Soil Samples
10%
Topoisomerase
10%
Western Ghats
10%
Docking Energy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
93%
Rituximab
93%
Cytokine
70%
Tetrahydrobiopterin
65%
Imatinib
62%
Chronic Myeloid Leukemia
62%
Cardiac Sarcoidosis
62%
Guanosine Triphosphate Cyclohydrolase I
59%
Antiproliferative Activity
52%
Moroxydine
47%
Edema
46%
Cytochrome C
40%
Caspase
35%
Diffuse Large B Cell Lymphoma
34%
Ifosfamide
31%
Atorvastatin
31%
Oxidized Low Density Lipoprotein
31%
Antiviral Therapy
31%
Membrane Antigen
31%
Hepatitis B Virus
31%
Protein Kinase Fer
31%
Adiponectin
31%
Nitric Oxide Donor
31%
Combination Therapy
31%
Cilostazol
31%
Protozoon
31%
Tetrahymena pyriformis
31%
Chemotherapy
31%
Nonhodgkin Lymphoma
31%
Heart Muscle Conduction Disturbance
31%
Carboplatin
31%
B Cell Lymphoma
31%
Atrioventricular Block
31%
Caffeic Acid
31%
Solanum Torvum
31%
Dexamethasone
31%
Janus Kinase
31%
Anthraquinone
31%
T Lymphocyte Receptor
31%
Etoposide
31%
Vascular Cell Adhesion Molecule 1
31%
Ischemic Heart Disease
31%
S-Nitroso-N-Acetylpenicillamine
20%
Tetrahymena
20%
Aromatic Levo Amino Acid Decarboxylase
20%
Caspase 3
19%
Complete Heart Block
15%
Acute Leukemia
15%
Nitric Oxide
15%
Acute Lymphoblastic Leukemia
15%
Acetic Acid Ethyl Ester
13%
Low Density Lipoprotein
12%
Tumor Necrosis Factor
12%
Triacylglycerol
12%
Colorectal Cancer
11%
Maintenance Dose
10%
Tumor Growth
10%
2 (4 Carboxyphenyl) 4,4,5,5 Tetramethylimidazoline 1 Oxyl 3 Oxide
10%
4 Ethyl 2 Hydroxyimino 5 Nitro 3 Hexenamide
10%
Linsidomine
10%
Antitumor Activity
10%
Ribosome Protein
10%
Tyrosinase
10%
Cooperative Binding
10%
Pteridine
10%
Phenylethanolamine N Methyltransferase
10%
Heart Ventricle Hypertrophy
10%
Herpes Zoster
10%
Deterioration
10%
Mouse Model
10%
Liver Cell Carcinoma
10%
Cytochrome C3
10%
Hexane
8%
Methanol
8%
Prostacyclin
7%
Forskolin
7%
Guanosine Triphosphate
7%
Iloprost
7%
Inflammation
7%
Systolic Dysfunction
7%
Western Blot
7%
Entecavir
7%
Malignant Neoplasm
7%
Varicella Zoster Virus
6%
Sulfonylurea Derivative
6%
Lactic Acid
6%
Congenital Malformation
6%
Gastrointestinal Disease
6%
Dictyostelium discoideum
6%
Saccharomyces cerevisiae
6%
Side Effect
6%
Regulator Protein
6%
Low Density Lipoprotein Cholesterol
6%
High Density Lipoprotein Cholesterol
6%
Myalgia
6%
Teratogenicity
6%
Epileptic Absence
5%
Minimum Bactericidal Concentration
5%
Micromonospora
5%
Biochemistry, Genetics and Molecular Biology
GTP Cyclohydrolase I
100%
Tetrahydrobiopterin
65%
Anabolism
65%
Cytokine
62%
Glibenclamide
31%
Hepatocyte
31%
Imatinib
31%
Cardiac Muscle Cell
31%
DNA Virus
31%
Surface Property
31%
Myeloid
31%
Chromosome 9
31%
RAC1
31%
B Cell
31%
VCAM-1
31%
Molecular Cloning
31%
Chimeric Antigen Receptor
31%
Fusion Transcript
31%
NUP98
31%
ETV6
31%
HOXA9
31%
Messenger RNA
23%
Cyclic Adenosine Monophosphate
20%
Reticulocyte Count
15%
RUNX1T1
15%
Granulopoiesis
15%
Reading Frame
15%
Fusion Gene
15%
Ape
15%
Tumor Necrosis Factor
15%
Glyceraldehyde 3-Phosphate Dehydrogenase
13%
Nitric Oxide
11%
Enzyme
10%
Hematopoiesis
10%
Cell Mediated Cytotoxicity
10%
Internalization
10%
Complement Dependent Cytotoxicity
10%
Ionotropic Glutamate Receptor
10%
Ionotropic Receptor
10%
Tetrahymena pyriformis
10%
Protozoon
10%
Phenylketonuria
10%
Sepiapterin Reductase
10%
Northern Blotting
7%
DNA Library
7%
Proinflammatory Cytokine
7%
Glycogenolysis
6%
Sulfonylurea
6%
Tetrahymena
6%
Heat Treatment
6%
Dictyostelium discoideum
6%
Iloprost
6%
Hemoglobin Synthesis
5%
Blood Transfusion
5%
Prostacyclin
5%
Product Inhibition
5%
Feedback System
5%
cAMP Signaling
5%